New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.

Sehouli, Jalid; Koensgen, Dominique; Oskay-Ozcelik, Gülten; Mustea, Alexander

Sehouli, Jalid; Koensgen, Dominique; Oskay-Ozcelik, Gülten; Mustea, Alexander.

Affiliation

Sehouli J; Department of Obstetrics and Gynecology, Charité University Hospital, Campus Virchow-Clinic, Berlin, Germany. sehouli@aol.com

Crit Rev Oncol Hematol ; 67(3): 204-12, 2008 Sep.

Article in En | MEDLINE | ID: mdl-18407513

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Endometrial Neoplasms/drug therapy; Endometrial Neoplasms/pathology; Carboplatin/administration & dosage; Carboplatin/toxicity; Chemotherapy, Adjuvant/standards; Chemotherapy, Adjuvant/trends; Cisplatin/administration & dosage; Cisplatin/toxicity; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Doxorubicin/administration & dosage; Doxorubicin/toxicity; Female; Forecasting; Granulocyte Colony-Stimulating Factor/administration & dosage; Humans; Neoplasm Staging; Paclitaxel/administration & dosage; Paclitaxel/toxicity; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Endometrial Neoplasms Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google